Medscape InDiscussion: Multiple Myeloma
57 FOLLOWERS
Join Dr. Joseph Mikhael for Medscape InDiscussion: Multiple Myeloma, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care.
Medscape InDiscussion: Multiple Myeloma
1y ago
Drs Joseph Mikhael and Brandon Blue reveal the impact of disparities in multiple myeloma and pave a path forward to culturally competent care.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/964342). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Multiple Myeloma Awareness and African American Disparities https://www.cancer.gov/about-nci/organization/crchd/blog/2017/multiple-myeloma-disparities
Multiple Myeloma ht ..read more
Medscape InDiscussion: Multiple Myeloma
1y ago
Drs Joseph Mikhael and Nina Shah discuss the exciting future in multiple myeloma in which bispecifics, CELMoDs, modakafusp, and easily delivered CAR T-cell therapy all may play a role.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/964340). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
International Myeloma Foundation https://www.myeloma.org/
CAR T-Cell Therapy for Multiple Myeloma https://decisionpoint.medscape ..read more
Medscape InDiscussion: Multiple Myeloma
1y ago
Joseph Mikhael, MD, and Saad Usmani, MD, discuss options in managing triple-class refractory multiple myeloma including selinexor, belantamab mafodotin, and CAR T-cell therapy.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/964339). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Multiple Myeloma https://emedicine.medscape.com/article/204369-overview
Selinexor Prescribing Information https://www.karyopharm.com/wp ..read more
Medscape InDiscussion: Multiple Myeloma
1y ago
Joseph Mikhael, MD, and Ashley Rosko, MD, discuss the role of comorbidities in multiple myeloma and stress the importance of shifting away from the sole use of age-based treatment decisions.
Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/964338). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Multiple Myeloma https://emedicine.medscape.com/article/204369-overview
International Myeloma Working Group Frailty Sc ..read more
Medscape InDiscussion: Multiple Myeloma
1y ago
Joseph Mikhael, MD, and Peter Voorhees, MD, discuss frontline therapy for multiple myeloma and new options for both transplant-eligible and transplant-ineligible patients.
Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/964337). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
International Myeloma Foundation https://www.myeloma.org/
Lenalidomide, Bortezomib, and Dexamethasone (RVD) Regimen for Multiple Myeloma ..read more
Medscape InDiscussion: Multiple Myeloma
1y ago
Joseph Mikhael, MD, and Irene Ghobrial, MD, discuss screening high-risk populations for early-stage multiple myeloma and new techniques to detect it.
Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/964336). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852672/
Prevalence of Monoclonal Gammop ..read more